skip navigation links 
 
 Search Options 
Index | Site Map | FAQ | Facility Info | Reading Rm | New | Help | Glossary | Contact Us blue spacer  
secondary page banner Return to NRC Home Page
NRC Seal
NRC NEWS
U.S. NUCLEAR REGULATORY COMMISSION
Office of Public Affairs Telephone: 301/415-8200
Washington, DC 20555-0001 E-mail: opa@nrc.gov
www.nrc.gov

No. 06-048 April 6, 2006

NRC ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES
TO MEET APRIL 25-26, 2006
Printable Version PDF Icon


The Nuclear Regulatory Commission’s Advisory Committee on Medical Uses of Isotopes will hold a public meeting April 25 and 26 in Bethesda, Md. Committee members will discuss agenda items including: (1) Updates on Proposed Regulations to Include Discrete Radium Sources and Accelerator-Produced Radioactive Materials in 10 CFR 35; (2) the Regulatory Issue Summary on Visitor Dose Limits; (3) Part 35, Training and Experience; (4) Supply of High Enriched Uranium for Molybdenum-99 Generation; (5) Training and Experience for Use of Microspheres for Therapy; and (6) ACMUI Review of Medical Events Involving I-131.

The public portion of the meeting will be from 10:30 a.m. to 5 p.m. on Tuesday and from 8 a.m. to 12 p.m. on Wednesday. The meeting will be held at the National Institute of Health, Natcher Conference Center, 45 Center Dr. Bethesda, Md., in Balcony B for the Tuesday session and Room E1/E2 for the Wednesday portion. Any member of the public wishing to submit a written statement or needing special assistance must contact Mohammad S. Saba, at 301-415-7608 or mss@nrc.gov . A transcript and written comments will be available on the NRC’s Web site, at http://www.nrc.gov and through the NRC Public Document Room on or about July 20, 2006.



Privacy Policy | Site Disclaimer
Thursday, February 22, 2007